☆ 3.8 Article

Thimet oligopeptidase as a potential CSF biomarker for Alzheimer's disease: A cross-platform validation study

ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Immunology

Neuroinflammatory CSF biomarkers MIF, sTREM1, and sTREM2 show dynamic expression profiles in Alzheimer's disease

Yanaika. S. S. Hok-A-Hin et al.

Summary: The proteins MIF and sTREM1 show different levels of expression in different stages of Alzheimer's disease, and they are associated with tau pathology and inflammation. These neuroinflammatory markers could be useful in clinical trials to monitor the dynamics of inflammatory responses or the efficacy of inflammatory modulating drugs.

JOURNAL OF NEUROINFLAMMATION (2023)

添加到收藏夹

Article Clinical Neurology

Associating Alzheimer's disease pathology with its cerebrospinal fluid biomarkers

Claire Bridel et al.

Summary: This study examines the relationship between neuropathology and CSF biomarkers in Alzheimer's disease patients, finding that the associations are stronger and more significant with longer intervals between lumbar puncture and death. This suggests that CSF biomarkers may not be well suited for monitoring neuropathological changes at later disease stages.

BRAIN (2022)

添加到收藏夹

Article Clinical Neurology

Alzheimer's disease clinical trial update 2019-2021

Joseph Pleen et al.

Summary: The review of clinical trials targeting Alzheimer's disease from 2019 to 2021 showed that the role of biomarkers is expanding, but there are still many challenges in targeting disease modification of AD. New clinical and observational trials are focusing on prevention and diverse biological processes that influence AD pathology to halt or slow clinical progression of the disease.

JOURNAL OF NEUROLOGY (2022)

添加到收藏夹

Editorial Material Pharmacology & Pharmacy

Blood-Based Alzheimer's Biomarkers

[Anonymous]

CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)

添加到收藏夹

Article Clinical Neurology

Multi-platform proteomic analysis of Alzheimer's disease cerebrospinal fluid and plasma reveals network biomarkers associated with proteostasis and the matrisome

Eric B. Dammer et al.

Summary: Robust and accessible biomarkers are urgently needed for the study of Alzheimer's disease. The study found correlations between protein markers in CSF and plasma, with greater variability in plasma. Proteomic analysis revealed changes in protein co-expression modules related to autophagy, ubiquitination, sugar metabolism, and other processes.

ALZHEIMERS RESEARCH & THERAPY (2022)

添加到收藏夹

Article Clinical Neurology

Multi-Omics Interdisciplinary Research Integration to Accelerate Dementia Biomarker Development (MIRIADE)

Ekaterina Mavrina et al.

Summary: This review discusses the experimental design of the Marie Curie MIRIADE project, which aims to accelerate the validation and implementation of novel biomarkers in clinical practice. The study addresses the technology-translation gap in biomarker discovery and validation, as well as the limited understanding of biomarker protein conformational states in different matrices. The article also describes the decision process of shortlisting biomarkers for development and the development of computational protein state and interaction prediction models.

FRONTIERS IN NEUROLOGY (2022)

添加到收藏夹

Article Neurosciences

Apolipoprotein L1 is increased in frontotemporal lobar degeneration post-mortem brain but not in ante-mortem cerebrospinal fluid

Yanaika S. Hok-A-Hin et al.

Summary: This study found increased levels of APOL1 in FTLD post-mortem brain tissue, regardless of the pathological subtypes. APOL1 was mainly expressed in neuronal and glial cells, but did not co-localize with pTau or pTDP-43. However, the levels of APOL1 in CSF were comparable between FTD patients and controls, and between pathological subtypes.

NEUROBIOLOGY OF DISEASE (2022)

添加到收藏夹

Article Cell Biology

CSF proteome profiling across the Alzheimer's disease spectrum reflects the multifactorial nature of the disease and identifies specific biomarker panels

Marta del Campo et al.

Summary: This study identifies specific dysregulated CSF proteins along the AD continuum, reflecting the multifactorial nature of disease progression. Some of these dysregulated proteins can be used as biomarkers for the diagnosis and clinical trials of AD.

NATURE AGING (2022)

添加到收藏夹

Review Clinical Neurology

Alzheimer's disease drug development pipeline: 2022

Jeffrey Cummings et al.

Summary: Alzheimer's disease is a global health crisis, and there are numerous clinical trials and drugs in development to treat and improve the symptoms and progression of the disease. The pipeline of drug development includes a diverse array of treatments, including disease-modifying therapies, cognitive enhancing treatments, and drugs for neuropsychiatric symptoms. Advances in drug design, outcome measures, biomarker use, and trial conduct show promise in accelerating the delivery of new and improved treatments for Alzheimer's disease patients.

ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2022)

添加到收藏夹

Review Clinical Neurology

Blood-based biomarkers for Alzheimer's disease: towards clinical implementation

Charlotte E. Teunissen et al.

Summary: Recent research suggests that blood-based biomarkers for Alzheimer's disease may become a reality, with consistent results across different cohorts. Additionally, other blood-based biomarkers can provide information about disease progression and treatment effects.

LANCET NEUROLOGY (2022)

添加到收藏夹

Article Biochemical Research Methods

Multiplatform Approach for Plasma Proteomics: Complementarity of Olink Proximity Extension Assay Technology to Mass Spectrometry-Based Protein Profiling

Agnese Petrera et al.

Summary: The plasma proteome is a valuable resource for biomarker discovery, and can be analyzed using tools like LC-MS/MS and PEA. By combining different platforms, researchers can gain deeper insights into the complexity of the plasma proteome and discover changes in pathophysiological status. This approach shows promise for future biomarker and mechanistic studies.

JOURNAL OF PROTEOME RESEARCH (2021)

添加到收藏夹

Article Clinical Neurology

Characterization of symptoms and determinants of disease burden in dementia with Lewy bodies: DEvELOP design and baseline results

M. van de Beek et al.

Summary: The DEvELOP project aims to phenotype patients with dementia with Lewy bodies and study the associations between symptoms and disease burden. The study found that cognitive and motor symptoms are related to daily functioning, while negative neuropsychiatric symptoms and functional dependency are important determinants of quality of life and caregiver burden. Follow-up research is ongoing to address specific gaps in DLB research.

ALZHEIMERS RESEARCH & THERAPY (2021)

添加到收藏夹

Review Neurosciences

Proteomic landscape of Alzheimer's Disease: novel insights into pathogenesis and biomarker discovery

Bing Bai et al.

Summary: Mass spectrometry-based proteomics plays a crucial role in Alzheimer's disease research, allowing for in-depth analysis of proteome and protein post-translational modifications. Studies have revealed not only known amyloid and tau pathways, but also novel protein networks in AD. Meta-analysis of deep datasets has identified a large number of differentially expressed proteins in the AD brain proteome, indicating the involvement of diverse cell types in Alzheimer's pathology.

MOLECULAR NEURODEGENERATION (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease

Jakob M. Bader et al.

MOLECULAR SYSTEMS BIOLOGY (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer's disease

Lenora Higginbotham et al.

SCIENCE ADVANCES (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

Thimet Oligopeptidase Biochemical and Biological Significances: Past, Present, and Future Directions

Emer S. Ferro et al.

BIOMOLECULES (2020)

添加到收藏夹

Article Clinical Neurology

Agreement of amyloid PET and CSF biomarkers for Alzheimer's disease on Lumipulse

Daniel Alcolea et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

Thimet Oligopeptidase (EC 3.4.24.15) Key Functions Suggested by Knockout Mice Phenotype Characterization

Nilton B. dos Santos et al.

BIOMOLECULES (2019)

添加到收藏夹

Article Biology

High throughput proteomics identifies a high-accuracy 11 plasma protein biomarker signature for ovarian cancer

Stefan Enroth et al.

COMMUNICATIONS BIOLOGY (2019)

添加到收藏夹

Article Clinical Neurology

The Sant Pau Initiative on Neurodegeneration (SPIN) cohort: A data set for biomarker discovery and validation in neurodegenerative disorders

Daniel Alcolea et al.

ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2019)

添加到收藏夹

Review Clinical Neurology

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

Clifford R. Jack et al.

ALZHEIMERS & DEMENTIA (2018)

添加到收藏夹

Review Neurosciences

Amsterdam Dementia Cohort: Performing Research to Optimize Care

Wiesje M. van der Flier et al.

JOURNAL OF ALZHEIMERS DISEASE (2018)

添加到收藏夹

Review Clinical Neurology

White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation

Charlotte E. Teunissen et al.

ALZHEIMERS RESEARCH & THERAPY (2018)

添加到收藏夹

Article Medical Laboratory Technology

Unbiased Approach to Counteract Upward Drift in Cerebrospinal Fluid Amyloid-β 1-42 Analysis Results

Betty M. Tijms et al.

CLINICAL CHEMISTRY (2018)

添加到收藏夹

Review Clinical Neurology

Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers

Giovanni B. Frisoni et al.

LANCET NEUROLOGY (2017)

添加到收藏夹

Review Clinical Neurology

Diagnosis and management of dementia with Lewy bodies Fourth consensus report of the DLB Consortium

Ian G. McKeith et al.

NEUROLOGY (2017)

添加到收藏夹

Article Rheumatology

Discovery of new candidate genes for rheumatoid arthritis through integration of genetic association data with expression pathway analysis

Klementy Shchetynsky et al.

ARTHRITIS RESEARCH & THERAPY (2017)

添加到收藏夹

Article Clinical Neurology

Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes

Lauren Walker et al.

ACTA NEUROPATHOLOGICA (2015)

添加到收藏夹

Article Biochemical Research Methods

A microfluidic multiplex proteomic immunoassay device for translational research

Jing Cao et al.

CLINICAL PROTEOMICS (2015)

添加到收藏夹

Article Clinical Neurology

A practical guide to immunoassay method validation

Ulf Andreasson et al.

FRONTIERS IN NEUROLOGY (2015)

添加到收藏夹

Article Clinical Neurology

The cerebrospinal fluid Alzheimer profile: Easily said, but what does it mean?

Flora H. Duits et al.

ALZHEIMERS & DEMENTIA (2014)

添加到收藏夹

Article Neurosciences

Optimizing Patient Care and Research: The Amsterdam Dementia Cohort

Wiesje M. van der Flier et al.

JOURNAL OF ALZHEIMERS DISEASE (2014)

添加到收藏夹

Review Biochemical Research Methods

Antibody-based proteomics and biomarker research-Current status and limitations

Corinne Solier et al.

PROTEOMICS (2014)

添加到收藏夹

Article Clinical Neurology

Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010

Thomas G. Beach et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2012)

添加到收藏夹

Editorial Material Medical Laboratory Technology

Biomarkers: hopes and challenges in the path from discovery to clinical practice

Nikolaos G. Frangogiannis

TRANSLATIONAL RESEARCH (2012)

添加到收藏夹

Article Clinical Neurology

The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Guy M. McKhann et al.

ALZHEIMERS & DEMENTIA (2011)

添加到收藏夹

Article Clinical Neurology

The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Marilyn S. Albert et al.

ALZHEIMERS & DEMENTIA (2011)

添加到收藏夹

Article Biochemical Research Methods

pROC: an open-source package for R and S plus to analyze and compare ROC curves

Xavier Robin et al.

BMC BIOINFORMATICS (2011)

添加到收藏夹

Review Clinical Neurology

A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking

C. E. Teunissen et al.

NEUROLOGY (2009)

添加到收藏夹

Article Neurosciences

Increased expression of the oligopeptidase THOP1 is a neuroprotective response to Aβ toxicity

Giuseppe Pollio et al.

NEUROBIOLOGY OF DISEASE (2008)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Protein biomarker discovery and validation: the long and uncertain path to clinical utility

Nader Rifai et al.

NATURE BIOTECHNOLOGY (2006)

添加到收藏夹

Article Biochemical Research Methods

Determination of β-amyloid peptide signatures in cerebrospinal fluid using immunoprecipitation-mass spectrometry

E Portelius et al.

JOURNAL OF PROTEOME RESEARCH (2006)

添加到收藏夹

Article Neurosciences

Comparative fine structural distribution of endopeptidase 24.15 (EC3.4.24.15) and 24.16 (EC3.4.24.16) in rat brain

JD Fontenele-Neto et al.

JOURNAL OF COMPARATIVE NEUROLOGY (2001)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.